Global Meningococcal Vaccine Market Set to Surge with Projected Growth to USD 9014 million by 2034

The global meningococcal vaccine market is on an impressive growth trajectory, driven by rising incidences of the disease worldwide. As of 2024, the market is valued at approximately USD 3950.2 million and is expected to soar to USD 9014 million by 2034, reflecting a remarkable Compound Annual Growth Rate (CAGR) of 8.6% during the forecast …

Meningococcal Vaccine Market to Reach USD 9014 Million by 2034 at a 8.6% of CAGR

The global meningococcal vaccine market is poised for robust growth, with an estimated valuation of USD 3950.2 million in 2024, projected to reach approximately USD 9014 million by 2034. This reflects a significant compound annual growth rate (CAGR) of 8.6% over the forecast period from 2024 to 2034. The growth of the meningococcal vaccine market …